460 related articles for article (PubMed ID: 16890350)
1. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
2. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
3. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
4. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
Sedaghat K; Finkelstein DI; Gundlach AL
Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
6. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of intraventricularly administered BMP-7 following a striatal 6-hydroxydopamine lesion.
Zuch CL; David D; Ujhelyi L; Hudson JL; Gerhardt GA; Kaplan PL; Bickford PC
Brain Res; 2004 Jun; 1010(1-2):10-6. PubMed ID: 15126112
[TBL] [Abstract][Full Text] [Related]
8. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
[TBL] [Abstract][Full Text] [Related]
9. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
[TBL] [Abstract][Full Text] [Related]
11. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
Ariano MA; Grissell AE; Littlejohn FC; Buchanan TM; Elsworth JD; Collier TJ; Steece-Collier K
J Neurosci Res; 2005 Nov; 82(3):387-96. PubMed ID: 16180225
[TBL] [Abstract][Full Text] [Related]
12. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
[TBL] [Abstract][Full Text] [Related]
13. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
Belluscio MA; Riquelme LA; Murer MG
Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
[TBL] [Abstract][Full Text] [Related]
14. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
15. Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain.
Yurek DM; Fletcher-Turner A
Exp Neurol; 2000 Jan; 161(1):392-6. PubMed ID: 10683304
[TBL] [Abstract][Full Text] [Related]
16. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
González-Hernández T; Barroso-Chinea P; Rodríguez M
Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
[TBL] [Abstract][Full Text] [Related]
17. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
Glavan G; Zivin M
Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
[TBL] [Abstract][Full Text] [Related]
19. Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism.
Brown AR; Hu B; Antle MC; Teskey GC
Exp Neurol; 2009 Nov; 220(1):162-70. PubMed ID: 19703443
[TBL] [Abstract][Full Text] [Related]
20. Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model.
Shyu WC; Li KW; Peng HF; Lin SZ; Liu RS; Wang HJ; Su CY; Lee YJ; Li H
J Neurosci Res; 2009 Jul; 87(9):2020-33. PubMed ID: 19235891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
